Fierce Biotech
FDA solicits feedback on controversial national priority voucher review pathway
The FDA has scheduled a public hearing for June 12 to hear input on the Commissioner’s National Priority Voucher program, which it introduced last June. So far, the program has resulted in four ultraspeedy drug reviews.